Literature DB >> 9063418

Expired nitric oxide as a marker for childhood asthma.

B V Nelson1, S Sears, J Woods, C Y Ling, J Hunt, L M Clapper, B Gaston.   

Abstract

Expression of the inflammatory isoform of the enzyme nitric oxide synthase (NOS) is increased in airway-lining cells of patients with asthma. The NOS product nitric oxide (NO.) was measured in the expired gas of children with asthma. Vital capacity expirates from 21 control subjects and 13 subjects with asthma were assayed by chemiluminescence. Measurements were highly reproducible (coefficient of variation, 2.6% +/- 1.1%) and did not vary with age, sex, height, or weight. Patients with asthma had mean NO. levels (16.3 parts per billion) that were more than threefold higher than those of control subjects (5.05 ppb; p < 0.001). Expired NO. decreased as airflow obstruction improved during corticosteroid treatment (r2 = 0.77; n = 7; p < 0.001) but remained higher than normal (13.5 ppb; n = 5; p < 0.01) even after airflow obstruction resolved. We demonstrate the use of a reproducible test for asthma in children that is independent of measures of airflow obstruction. We speculate that expired NO assays may prove to be a more sensitive measure of childhood asthma than spirometry.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063418     DOI: 10.1016/s0022-3476(97)70204-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Sinus computed tomography scan and markers of inflammation in vocal cord dysfunction and asthma.

Authors:  Edward J Peters; Tina K Hatley; Scott E Crater; C Douglas Phillips; Thomas A E Platts-Mills; Larry Borish
Journal:  Ann Allergy Asthma Immunol       Date:  2003-03       Impact factor: 6.347

2.  Exhaled nitric oxide levels in non-allergic and allergic mono- or polysensitised children with asthma.

Authors:  M Silvestri; F Sabatini; D Spallarossa; L Fregonese; E Battistini; M G Biraghi; G A Rossi
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

3.  Controlled low flow off line sampling of exhaled nitric oxide in children.

Authors:  Q Jöbsis; H C Raatgeep; W C Hop; J C de Jongste
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

4.  Salmeterol in paediatric asthma.

Authors:  C Byrnes; S Shrewsbury; P J Barnes; A Bush
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

5.  Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans.

Authors:  Elena N Atochina-Vasserman; Carla Winkler; Helen Abramova; Frank Schaumann; Norbert Krug; Andrew J Gow; Michael F Beers; Jens M Hohlfeld
Journal:  Am J Respir Crit Care Med       Date:  2010-12-03       Impact factor: 21.405

6.  Concentration of nitric oxide products in bronchoalveolar fluid obtained from infants who develop chronic lung disease of prematurity.

Authors:  J R Vyas; A E Currie; D E Shuker; D J Field; S Kotecha
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-11       Impact factor: 5.747

7.  Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide.

Authors:  Anne M Fitzpatrick; Benjamin M Gaston; Serpil C Erzurum; W Gerald Teague
Journal:  J Allergy Clin Immunol       Date:  2006-10-10       Impact factor: 10.793

8.  In vitro cytotoxicity and mutagenicity of mainstream waterpipe smoke and its functional consequences on alveolar type II derived cells.

Authors:  Mayyasa Rammah; Farah Dandachi; Rola Salman; Alan Shihadeh; Marwan El-Sabban
Journal:  Toxicol Lett       Date:  2012-04-10       Impact factor: 4.372

Review 9.  Biomarkers in asthma: a real hope to better manage asthma.

Authors:  Serpil C Erzurum; Benjamin M Gaston
Journal:  Clin Chest Med       Date:  2012-07-25       Impact factor: 2.878

10.  Evaluation of the long-term pancreatic effects of constitutive nitric oxide synthase inhibition in dogs.

Authors:  K L Kolaja; R R Bell; D Janssen; P T Manning; M J Schlosser; K N M Khan
Journal:  Inflammopharmacology       Date:  2004       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.